J 2022

The EHA Research Roadmap: Malignant Lymphoid Diseases

DREYLING, Martin, Marc ANDRE, Nicola GOKBUGET, Herve TILLY, Mats JERKEMAN et. al.

Základní údaje

Originální název

The EHA Research Roadmap: Malignant Lymphoid Diseases

Autoři

DREYLING, Martin (garant), Marc ANDRE, Nicola GOKBUGET, Herve TILLY, Mats JERKEMAN, John GRIBBEN, Andres FERRERI, Pierre MOREL, Stephan STILGENBAUER, Christopher FOX, Maria Ribera JOSE, Sonja ZWEEGMAN, Igor AURER, Csaba BODOR, Birgit BURKHARDT, Christian BUSKE, Dollores Caballero MARIA, Elias CAMPO, Bjoern CHAPUY, Andrew DAVIES, de Leval LAURENCE, Jeanette DOORDUIJN, Massimo FEDERICO, Philippe GAULARD, Francesca GAY, Paolo GHIA, Kirsten GRONBAEK, Hartmut GOLDSCHMIDT, Marie-Jose KERSTEN, Barbara KIESEWETTER, Judith LANDMAN-PARKER, Le Gouill STEVEN, Georg LENZ, Sirpa LEPPA, Armando LOPEZ-GUILLERMO, Elizabeth MACINTYRE, Maria Victoria Mateos MANTEGA, Philippe MOREAU, Carol MORENO, Bertrand NADEL, Jessica OKOSUN, Roger OWEN, Šárka POSPÍŠILOVÁ (203 Česká republika, domácí), Christiane POTT, Tadeusz ROBAK, Michelle SPINA, Kostas STAMATOPOULOS, Jan STARY, Karin TARTE, Allessandra TEDESCHI, Catherine THIEBLEMONT, Ralf Ulrich TRAPPE, Lorenz H TRUMPER a Gilles SALLES

Vydání

HemaSphere, Philadelphia, Lippincott Williams & Wilkins, 2022, 2572-9241

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30205 Hematology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 6.600

Kód RIV

RIV/00216224:14110/22:00126413

Organizační jednotka

Lékařská fakulta

UT WoS

000797600900001

Klíčová slova anglicky

Malignant Lymphoid Diseases; EHA Research Roadmap

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 16. 1. 2023 14:11, Mgr. Tereza Miškechová

Anotace

V originále

In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research aiming to highlight achievements in the diagnostics and treatment of blood disorders and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1 to 2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cell-based Immune Therapies; and Gene Therapy.